Avid Bioservices Inc (CDMO)

[biopharm]

May 28, 2015 02:04 PM Eastern Daylight Time

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) will host a teleconference on Monday, June 1, 2015, at 7 p.m. EDT (6 p.m. CDT) to review data presented at the Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago. Company executives will provide an overview of data presented at the meeting, with a focus on the company’s immuno-oncology portfolio, and address inquiries from investors and analysts.

http://www.businesswire.com/news/home/20150528006391/en/Bristol-Myers-Squibb-Hold-Investor-Teleconference-Discuss-ASCO#.VWfq10b76So

... maybe we find out if BMS execs are lacking in how much they truly know about PS Targeting, because if many start asking about Yervoy+Bavituximab ..etc..etc, then I'm sure BMS may finally be forced to speak about PS Targeting broad applications and possibilities...